title: Epidermal growth factor-dependent regulation of Cdc42 is mediated by the Src tyrosine kinase.
abstract: Treatment of cells with epidermal growth factor (EGF) promotes the activation of the small GTP-binding protein Cdc42, as well as its phosphorylation in cells. The EGF-dependent phosphorylation of Cdc42 occurs at tyrosine 64 in the Switch II domain and appears to be mediated through the Src tyrosine kinase, because both the expression of a dominant-negative Src mutant (mouse Src(K297R)) and treatment of cells with the Src kinase inhibitor PP2 blocks the EGF-stimulated phosphorylation of Cdc42, whereas expression of an activated Src mutant (Src(Y529F)) promotes phosphorylation in the absence of EGF treatment. The EGF-stimulated phosphorylation of Cdc42 is not required for its activation, nor does it directly affect the interactions of activated Cdc42 with target/effector proteins including PAK, ACK, WASP, or IQGAP. However, the EGF-stimulated phosphorylation of Cdc42 is accompanied by an enhancement in the interaction of Cdc42 with the Rho-GDP dissociation inhibitor (RhoGDI). The EGF-stimulated activation of Cdc42 does require activated Src, as well as the Vav2 protein, a member of the Dbl family of guanine nucleotide exchange factors. Src catalyzes the tyrosine phosphorylation of Vav2, and overexpression of Vav2 together with activated Src (Src(Y529F)) can completely bypass the need for EGF to promote the activation of Cdc42. Thus, EGF signaling through Src appears to have dual regulatory effects on Cdc42: 1). it leads to the activation of Cdc42 as mediated by the Vav2 guanine nucleotide exchange factor, and 2). it results in the phosphorylation of Cdc42, which stimulates the binding of RhoGDI, perhaps to direct the movement of Cdc42 to a specific cellular site to trigger a signaling response, because Cdc42-RhoGDI interactions are essential for Cdc42-induced cellular transformation.
mesh_terms: D000818:Animals; D002384:Catalysis; D002460:Cell Line; D004815:Epidermal Growth Factor / Q000502:physiology*; D006801:Humans; D015513:Oncogene Proteins / Q000378:metabolism; D010766:Phosphorylation; D051567:Proto-Oncogene Proteins c-vav; D015398:Signal Transduction; D014443:Tyrosine / Q000378:metabolism; D020764:cdc42 GTP-Binding Protein / Q000737:chemistry / Q000378:metabolism / Q000502:physiology*; D019061:src-Family Kinases / Q000502:physiology*
chemical_list: D015513:Oncogene Proteins; D051567:Proto-Oncogene Proteins c-vav; C093651:VAV2 protein, human; C490565:Vav2 protein, mouse; D014443:Tyrosine; D004815:Epidermal Growth Factor; D019061:src-Family Kinases; D020764:cdc42 GTP-Binding Protein